Yuanyuan Liu1, Shafei Wu1, Xiaohua Shi1, Zhiyong Liang1, Xuan Zeng2. 1. Department of Pathology, Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences, Beijing, 100730, China. 2. Department of Pathology, Peking Union Medical College Hospital, Molecular Pathology Research Center, Chinese Academy of Medical Sciences, Beijing, 100730, China. zengxuan88@yahoo.com.
Abstract
PURPOSE: IHC, FISH, and NGS are common methods of ALK evaluation in NSCLC. The purpose of this study was to investigate whether ALK false positives or false negatives occurred more often in daily routines. An approach to identify ALK fusion was then proposed. MATERIALS AND METHODS: We analyzed 1815 cases of NSCLC, including 83 (4.6%) ALK IHC positives. Total 182 samples (62 ALK+ and 120 ALK-) were examined via FISH, RT-ddPCR, NGS, RT-qPCR and RNAscope to confirm ALK status. RESULTS: One ALK FISH false negative was found, which harbored two genomic rearrangements involved in EML4-ALK (exon 13:exon 20) fusion. One ALK IHC false negative was confirmed depending on a rare ALK FISH-positive pattern and ALK RNAscope positive but ALK fusion was not found via NGS. In addition, an atypical ALK FISH-positive pattern was observed in an IHC-positive case with chromosome 2 inversion leading to EML4-ALK (exon 6:exon 20) fusion. EML4-ALK fusion was determined in one case with an atypical FISH patterns by RT-qPCR. Rare complicated genomic rearrangements involved in a novel ALK fusion of EML4-ALK (exon 7:exon 14) were distinguished in an ALK IHC and FISH double-positive case. CONCLUSION: False negative of ALK IHC, FISH and NGS results were found in our cohort, but none was false ALK positive. False ALK negatives should be more concerned than false positives. ALK rearrangements with cryptic ALK fusion patterns could be identified using our algorithm. Non-squamous non-small cell lung cancer was recommended for priority detection.
PURPOSE: IHC, FISH, and NGS are common methods of ALK evaluation in NSCLC. The purpose of this study was to investigate whether ALK false positives or false negatives occurred more often in daily routines. An approach to identify ALK fusion was then proposed. MATERIALS AND METHODS: We analyzed 1815 cases of NSCLC, including 83 (4.6%) ALK IHC positives. Total 182 samples (62 ALK+ and 120 ALK-) were examined via FISH, RT-ddPCR, NGS, RT-qPCR and RNAscope to confirm ALK status. RESULTS: One ALK FISH false negative was found, which harbored two genomic rearrangements involved in EML4-ALK (exon 13:exon 20) fusion. One ALK IHC false negative was confirmed depending on a rare ALK FISH-positive pattern and ALK RNAscope positive but ALK fusion was not found via NGS. In addition, an atypical ALK FISH-positive pattern was observed in an IHC-positive case with chromosome 2 inversion leading to EML4-ALK (exon 6:exon 20) fusion. EML4-ALK fusion was determined in one case with an atypical FISH patterns by RT-qPCR. Rare complicated genomic rearrangements involved in a novel ALK fusion of EML4-ALK (exon 7:exon 14) were distinguished in an ALK IHC and FISH double-positive case. CONCLUSION: False negative of ALK IHC, FISH and NGS results were found in our cohort, but none was false ALK positive. False ALK negatives should be more concerned than false positives. ALK rearrangements with cryptic ALK fusion patterns could be identified using our algorithm. Non-squamous non-small cell lung cancer was recommended for priority detection.
Authors: Christina Selinger; Wendy Cooper; Trina Lum; Catriona McNeil; Adrienne Morey; Paul Waring; Benhur Amanuel; Michael Millward; Joanne Peverall; Chris Van Vliet; Michael Christie; Yen Tran; Connie Diakos; Nick Pavlakis; Anthony J Gill; Sandra O'Toole Journal: Histopathology Date: 2015-05-24 Impact factor: 5.087
Authors: X C Zhang; S Lu; L Zhang; M L Liao; C L Wang; Y Cheng; G D Li; S J Mok; C Huang; X Q Liu; J Wang; M Z Wang; Y P Zhang; J Y Zhou; X J Zhou; X Y Zhou; D M Lin; J J Yang; Y Song; C P Hu; K Wang; Y He; H Li; W Z Zhong; Y L Wu Journal: Zhonghua Bing Li Xue Za Zhi Date: 2018-04-08
Authors: Eugen C Minca; Bryce P Portier; Zhen Wang; Christopher Lanigan; Carol F Farver; Yan Feng; Patrick C Ma; Valeria A Arrossi; Nathan A Pennell; Raymond R Tubbs Journal: J Mol Diagn Date: 2013-03-13 Impact factor: 5.568
Authors: Shengxiang Ren; Fred R Hirsch; Marileila Varella-Garcia; Dara L Aisner; Theresa Boyle; Caicun Zhou; D Ross Camidge Journal: J Thorac Oncol Date: 2014-03 Impact factor: 15.609